How Low Can We Go? Readdressing Antibiotic Duration for Common Childhood Infections

Size: px
Start display at page:

Download "How Low Can We Go? Readdressing Antibiotic Duration for Common Childhood Infections"

Transcription

1 How Low Can We Go? Readdressing Antibiotic Duration for Common Childhood Infections Rebecca Levorson, MD Andrew Nuibe, MD, MSCI Pediatric Infectious Diseases

2 Disclosures Dr. Rebecca Levorson: I have no financial interests to disclose Dr. Andrew Nuibe: I have no financial interests to disclose Duration of therapy should be tailored to each individual case

3 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

4 Background Antimicrobials are the most prescribed medication class in pediatrics 1 Prolonged antimicrobial use has consequences Higher costs Increased risk for adverse outcome, e.g. rash Selects for resistant pathogens 1 Chai G et al. Pediatrics 2012

5 Rationale 20-50% of all antibiotics prescribed in U.S. acute care hospitals are either unnecessary or inappropriate The misuse of antibiotics has also contributed to the growing problem of antibiotic resistance, which has become one of the most serious and growing threats to public health.

6

7 In the United States Over 2,000,000 people infected with antibiotic-resistant organisms Approximately 23,000 deaths annually in the United States due to antibiotic resistant infections.

8

9 In the United States million courses of antibiotics are written in the outpatient setting yearly. >5 prescriptions/6 people/year in the United States. Local outpatient prescribing practices contribute to local resistance patterns. Azithromycin and amoxicillin are among the most commonly prescribed antibiotics.

10 We Have a PROBLEM!

11 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

12 S.pyogenes Pharyngitis Duration 1940s-1950s: 10 days penicillin studied for prevention of rheumatic fever : 7d versus 10d penicillin PO TID 4 Positive throat culture on follow up at 21 days 7 days PCN (n = 96) 10 days PCN (n=95) 31% 18% 1 Goerner JR et al. NEJM Massell BF et al. JAMA Denny FW et al. JAMA Schwartz RH et al. JAMA 1981

13 S.pyogenes Pharyngitis 1991: 5 days azithromycin versus 10 days penicillin PO q6h 1 Similar improvement and eradication Current U.S. macrolide resistance as high as 50% 2,3 Recommended dosing: 12 mg/kg/dose for 5 days : 6 days amoxicillin BID versus 10 days penicillin PO TID 5 Similar improvement and eradication 1 Hooton TM Am J Med Green M et al. Antimicrob Agents Chemother Martin JM et al. NEJM Shulman ST et al. CID Cohen R et al. PIDJ 1996

14 S.pyogenes Pharyngitis Duration 1997, 1998: 5d cefdinir BID or 5d cefpodoxime BID versus 10 days penicillin PO TID 1,2 Negative throat culture 5d Cefdinir (n=224) 10d PCN (n=216) 5d Cefpodoxime (n=126) 10d PCN (n=130) 90% 72% 75% 76% 1 Tack KJ et al. Arch Pediatric Adol Med Pichichero ME et al. Arch Pediatr Adoles Med 1994

15 S. pyogenes Pharyngitis Duration Conclusions: 10 days of penicillin or amoxicillin recommended first line therapy for optimal eradication 1 < 10 days of amox, azithro, cefdinir, cefpodoxime effective for symptom relief and eradication Unclear whether < 10 days therapy is effective in preventing rheumatic fever 1 Shulman ST et al. CID 2012

16 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

17 Uncomplicated CAP Duration S.pneumoniae considered major bacterial pathogen in immunized, previously healthy 1 10 days of amoxicillin BID is standard, cost-effective choice for S.pneumoniae CAP 1,2 1 Bradley JS et al. CID Lorgelly PK et al. Eur Resp J 2010

18 Uncomplicated CAP Duration 2002, 2004: 3d vs 5d Amoxicillin TID 1,2 Similar clinical outcomes but ~20% had RSV 2014: 3d vs 10d, 5d vs 10d amoxicillin 3 5 days non-inferior to 10 days Treatment failure 3 d Amoxicillin (n=10) 5 d Amoxicillin (n=56) 10 d Amoxicillin (n=59) Pakistan Multicentre Amoxicillin Short Course Therapy (MASCOT) pneumonia study group. Lancet ISCAP Study Group. BMJ Greenberg D et al. PIDJ 2014

19 Uncomplicated CAP Duration Conclusions: 10 days of amoxicillin recommended for mild-tomoderate S.pneumoniae CAP days of amoxicillin 90 mg/kg/day is acceptable for mild outpatient CAP 1 Be wary of using oral cephalosporins and macrolides for S.pneumoniae CAP 1 Bradley JS et al. CID 2012

20 Atypical CAP Duration Mycoplasma pneumoniae CAP Azithromycin 3 d at 10/kg vs. 5 d at 10/kg x1 then 5/kg x 4 d

21 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

22 Uncomplicated Cellulitis Duration Typically due to S. aureus and S. pyogenes Increasing cellulitis incidence in MRSA era 1 Wide variation in management for SSTIs 2,3 2004: 5d vs 10d levofloxacin for cellulitis 4 Similar clinical outcomes in both groups 2016: < 7 days for non-suppurative cellulitis 5 Therapy < 7 days not associated with higher recurrence cf. longer therapy 1 Dukc VM et al. PLoS One Mistry RD et al. Acad Emerg Med Moore SJ et al. PIDJ Hepburn MJ et al. Arch Int Med Shuler CL Pediatrics 2016

23 Uncomplicated Cellulitis Duration Conclusions: 5 days of therapy for S. aureus and S. pyogenes acceptable for uncomplicated cellulitis 1 Can extend duration if not improving 1 Stevens DL et al. CID 2014

24 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

25 Acute Osteoarticular Infection Duration 1967: Arbitrarily treated for 5 weeks 1 Thought that debrided bone took 4 weeks to revascularize 2 Parenteral therapy < 3 weeks tied to chronic disease 3,4 Typically treat pyogenic arthritis for 2-3 weeks and osteomyelitis for 4-6 weeks 1 Green JH. Br Med J Lazzarini L et al. J Bone Joint Surg Dich VQ et al. Am J Dis Child O Brien et al. J Bone Joint Surg 1982

26 Acute Osteoarticular Infection Duration 1997: 3-4 wks of 1G cephalosporin or clindamycin for acute S.aureus osteomyelitis 1 No treatment failure or long term sequelae 2009: 10d vs 30d 1G cephalosporin or clindamycin for S.aureus pyogenic arthritis 2 No treatment failure with shorter course if initial clinical response was robust 1 Peltola et al. Pediatrics Peltola et al. CID 2009

27 Acute Osteoarticular Infection Duration Conclusions: Pyogenic arthritis can be treated for days if initial robust response Osteomyelitis can be treated for 3-4 weeks if initial robust response

28 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

29 Urinary Tract Infections

30 Pediatric UTIs Pyuria + Positive Urine Culture 85% E. coli AAP guidelines 2011 (2 mo to 2 years) UA + antibiogram initial empiric therapy Increasing MDRO UTIs in USA (esp. DC area)

31 Lower UTIs 1981: 1 d vs. 10 d: short course less effective in preventing recurrent infection , 2012: No difference in persistent bacteriuria or recurrence between 2-4 days and 7-14 days of oral antibiotics. 2,3 2011: Adult guidelines suggest 3-5 days antibiotics 4 1 McCracken et al., Pediatrics 1981; 67; Michael M, et al., Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev 2003; 1:CD Fitzgerald A, et al., Antibiotics for treating lower urinary tract infection in children. Cochrane Database Syst Rev 2012; 8: CD Gupta K, et al., CID 2011:52, 5:e

32 Acute Pyelonephritis and Febrile UTIs IV oral vs. all oral antibiotics for 14 days no difference in renal scarring or recurrence rates even in bacteremia 1, day courses inferior to 7-10 day courses for febrile UTIs 3, 4 Ongoing NIH sponsored trial for 5 days vs. 10 days for febrile UTI, Acute Pyelonephritis in kids 1 Bocquet N, et al. Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children. Pediatrics 2012; 129:e Hoberman A, et al., Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999; 104: Grimwood K, et al., N Z Med J 1988; 24;101 4 AAP 2011: UTI clinical practice guidelines; Pediatrics

33 Pediatric UTI Treatment Conclusions Uncomplicated cystitis: 3-5 days Febrile UTI & Pyelonephritis: IV vs. po equal 7-14 days current AAP guidelines Awaiting NIH sponsored study results 5 vs. 10 days for pediatric pyelonephritis

34 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

35

36 Complicated intraabdominal infection, adequate source control, randomized to antibiotics for 2 days after resolution of fever, leukocytosis, and ileus with max of 10 days (control) vs. 4+/- 1 day of antibiotics Approximately 4 days were similar to those after a longer course of antibiotics (approximately 8 days) that extended until after the resolution of physiological abnormalities. Sawyer RG, et al., N Engl J Med 2015;372:

37 Intra-abdominal Infections 1. Uncomplicated appendicitis (without perforation) Single perioperative dose of antibiotics (eg., cefoxitin) 2. Complicated appendicitis 4-7 days antibiotics sufficient Ceftriaxone/metronidazole can be given as once daily doses No difference between longer and shorter duration as long as adequate source control Low complication rates if IV antibiotics are stopped when patients are afebrile and tolerating diet 3. Abscessed Appendicitis If source control, as above If no source control planned, longer duration typical (~10-14 days) No specific duration recommendations Complicated Intra-abdominal Infection Guidelines CID 2010:50 (15 January)

38 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

39 Acute Bacterial Sinusitis Definition Acute URI with: Persistent illness (nasal discharge [of any quality] or daytime cough or both lasting more than 10 days without improvement) OR A worsening course (worsening or new onset of nasal discharge, daytime cough, or fever after initial improvement) OR Severe onset (concurrent fever >102.2 F and purulent nasal discharge for at least 3 consecutive days) Wald E, et al., Pediatrics 2013; 132; e262

40 Acute Bacterial Sinusitis Pathogens Estimated proportions in ABS based on middle ear infections 1 S. pneumoniae (30% cases) H. influenzae (30% cases) M. catarrhalis (10% cases) 25% sterile cultures 1 Casey JR, et al., PIDJ 2010

41 Acute Bacterial Sinusitis Treatment AAP Recommended duration: 7 days after symptom resolve with minimum duration of 10 days 1 IDSA Recommended duration: days 2 14% Placebo cure rate 3 1 Wald E, et al., Pediatrics 2013; 132; e262 2 Chow AW, et al., CID 2012;54; Wald E, et al., Pediatrics 2009; 124; 9

42 Objectives Review Recommended Duration of Antimicrobial Therapy for Common Childhood Infections including: Group A Streptococcal Pharyngitis CAP Typical & Atypical Cellulitis Acute osteomyelitis UTI Cystitis Pyelonephritis Intra-abdominal Infections Sinusitis Otitis Media Based on Clinical Guidelines and Clinical Studies

43 Acute Otitis Media Pathogens same as Acute Bacterial Sinusitis 2004 AAP Guidelines help with AOM diagnostic criteria, watch/wait 10 day course derived from S.pyogenes pharyngitis therapy : Augmentin BID 5d or 10d versus Augmentin TID 2 5 d not as effective, especially in < 2 yo 1 Lieberthal AS et al. Pediatrics Hoberman A et al. PIDJ 1997

44 Who to treat? Start Antibiotics Severe <2 yo Nonsevere bilateral <2 yo Close Observation OR Start Antibiotics Nonsevere Unilateral < 2yo Nonsevere AOM >2 yo

45

46 Acute Otitis Media Duration Majority due to bacteria 1 Standard 10 day course derived from S.pyogenes pharyngitis therapy : 5d versus 10d Augmentin BID 3 5 days Augmentin (n=197) 10 days Augmentin (n=178) Clinical cure at days % 69% 1 Jacobs Dr et al. Antimicrob Agents and Chemother Lieberthal AS et al. Pediatrics Hoberman A et al. PIDJ 1997

47 Acute Otitis Media Duration 2001: Antibiotics for 5, 7, or 10 days 5 days (n=707) 7 days (n=423) 10 days (n=1042) All ages Cured + Improved 82% 82% 83% 2 yo Cured + Improved 75% 73% 76% Pichichero ME et al. Otolaryngol Head Neck Surg 2001

48 Casey JR, et al., Ped Infect Dis J Aug;32(8):805-9.

49 Acute Otitis Media Duration Conclusions: < 2 yo should get 10 days of amoxicillin 2-5 yo can get 7 days of amoxicillin > 6 yo can get 5-7 days of amoxicillin Be wary of using oral cephalosporins and macrolides for S.pneumoniae 1 1 Lieberthal AS et al. Pediatrics 2013

50 USA: 34% Strep pneumo macrolide resistance 17% Strep pneumo Penicillin resistance

51 Acute Otitis Media Duration AOM incidence and epidemiology changing s/p PCV vaccine Marom et al. JAMA Pediatr 2014

52 Summary Opportunities remain to determine optimal length of therapy for many infections Thoughtfully consider the patient s response to therapy Return for Re-evaluation vs. Finish the Whole Bottle Educate Everyone including Patients and Parents as Antibiotics are a Shared Resource

53

54 PSV Pediatric Infectious Diseases Dr. Daniel Keim Dr. Rebecca Levorson Dr. Katherine Moyer Dr. Andrew Nuibe Dr. Brittany Goldberg

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,

More information

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children Prescribing Antimicrobials for Common Illnesses When treating common illnesses such as ear infections and strep throat,

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Let me clear my throat: empiric antibiotics in

Let me clear my throat: empiric antibiotics in Let me clear my throat: empiric antibiotics in respiratory tract infections Alexander John Langley, MD MS MPH Goals of this talk Overuse of antibiotics is a major issue, as a result many specialist medical

More information

Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550

Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Sinusitis Upper respiratory tract infections (URI) Common cold

More information

Approach to pediatric Antibiotics

Approach to pediatric Antibiotics Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gerber JS, Prasad PA, Fiks AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians:

More information

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018

ECHO: Management of URIs. Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 ECHO: Management of URIs Charles Krasner, M.D. Sierra NV Veterans Affairs Hospital University of NV, Reno School of Medicine October 16, 2018 Infectious causes of URIs change over time Most ARIs are viral

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

Duration of antibiotic therapy:

Duration of antibiotic therapy: Duration of antibiotic therapy: How low can you go? Thomas Holland, MD Hilton Head, SC July 2017 Disclosures Consulting: The Medicines Company, Basilea Pharmaceutica Adjudication committee: Achaogen Grant

More information

Antimicrobial Stewardship in Ambulatory Care

Antimicrobial Stewardship in Ambulatory Care Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

Update on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO

Update on Fluoroquinolones. Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Update on Fluoroquinolones Charles Krasner, M.D. June 16, 2016 Antibiotic Stewardship Program -ECHO Potential fluoroquinolone side-effects Increased risk, greater than with most other antibiotics, for

More information

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012 Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton

More information

Antibiotic Duration for Common Infections

Antibiotic Duration for Common Infections Antibiotic Duration for Common Infections Emily Spivak, MD, MHS Division of Infectious Diseases Medical Director, Antimicrobial Stewardship Program University of Utah Hospitals and Clinics Learning Objectives

More information

Telephone Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada. Sitemap

Telephone Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada. Sitemap Telephone 613-835-9490 Max dose amoxicillin pediatrics P.O. Box 189 Navan, ON, K4B 1J4 Canada Sitemap 25 mg/kg/ dose ( Max : 500 mg/ dose ) PO twice daily for 10 days is recommended by the Infectious Diseases

More information

Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs. Disclosure 4/22/17

Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs. Disclosure 4/22/17 Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs Elizabeth O. Hand, Pharm.D., BCPS Pediatric Infectious Disease Pharmacist University Health System Clinical Assistant Professor The

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

CLINICAL USE OF BETA-LACTAMS

CLINICAL USE OF BETA-LACTAMS CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial

More information

Rational management of community acquired infections

Rational management of community acquired infections Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?

More information

Delayed Prescribing for Minor Infections Resource Pack for Prescribers

Delayed Prescribing for Minor Infections Resource Pack for Prescribers Delayed Prescribing for Minor Infections Resource Pack for Prescribers Background: Antibiotic resistance is an alarming threat to modern healthcare, and infectious illness remains a major global threat

More information

Outpatient Antimicrobial Stewardship. Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia

Outpatient Antimicrobial Stewardship. Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia Outpatient Antimicrobial Stewardship Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia Overview The case for outpatient antimicrobial stewardship Interventions

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks Vapo Rub for Cold Symptoms

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks Vapo Rub for Cold Symptoms Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

Antibiotics in the trenches: An ER Doc s Perspective

Antibiotics in the trenches: An ER Doc s Perspective Antibiotics in the trenches: An ER Doc s Perspective Peter Currie, MD Medical Director for Quality Emergency Physicians Professional Association (EPPA) Agenda Emergency Medicine Specific Disease Processes

More information

Guidelines for Treatment of Urinary Tract Infections

Guidelines for Treatment of Urinary Tract Infections Guidelines for Treatment of Urinary Tract Infections Overview This document details the Michigan Hospital Medicine Safety (HMS) Consortium preferred antibiotic choices for treatment of uncomplicated and

More information

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA Upper Respiratory Infection (URI) GUIDELINE Summaries for Adults and Pediatrics. The guideline was reviewed and adopted by the Molina Healthcare of California Clinical Quality

More information

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018 Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium

More information

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose

3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of

More information

Safety of an Out-Patient Intravenous Antibiotics Programme

Safety of an Out-Patient Intravenous Antibiotics Programme Safety of an Out-Patient Intravenous Antibiotics Programme Chan VL, Tang ESK, Leung WS, Wong L, Cheung PS, Chu CM Department of Medicine & Geriatrics United Christian Hospital Outpatient Parental Antimicrobial

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Vicks VapoRub Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE

ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE Jane Sykes, BVSc(Hons), PhD, DACVIM (SAIM) School of Veterinary Medicine Dept. of Medicine & Epidemiology University of California Davis,

More information

Optimize Durations of Antimicrobial Therapy

Optimize Durations of Antimicrobial Therapy Optimize Durations of Antimicrobial Therapy Evidence & Application Jill Cowper, Pharm.D. Division Infectious Diseases Pharmacist Parallon Supply Chain Solutions Richmond, VA P: 607 221 5101 jill.butterfield@parallon.com

More information

Optimizing Antibiotic Stewardship in the ED

Optimizing Antibiotic Stewardship in the ED Optimizing Antibiotic Stewardship in the ED Michael Pulia, MD MS FAAEM FACEP Director, UW EM Antibiotic Stewardship Research Program Chair, AAEM Antimicrobial Stewardship Task Force @DrMichaelPulia Learning

More information

Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections

Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections 15th Annual Rocky Mountain Hospital Medicine Symposium November 6, 2017 Tim Jenkins, MD Director, Antibiotic Stewardship Program Denver

More information

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives

More information

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial

More information

Workshop on the use of antibiotics. Dr Rosemary Ikram FRCPA Consultant Clinical Microbiologist

Workshop on the use of antibiotics. Dr Rosemary Ikram FRCPA Consultant Clinical Microbiologist Workshop on the use of antibiotics. Dr Rosemary Ikram FRCPA Consultant Clinical Microbiologist Declaration of affiliations. Working with: BPAC, DHBSS laboratory schedule group, IANZ, Pharmacy Brands (UTI

More information

Volume 1; Number 7 November 2007

Volume 1; Number 7 November 2007 Volume 1; Number 7 November 2007 CONTENTS Page 1 Page 3 Guidance on the Use of Antibacterial Drugs in Lincolnshire Primary Care: Winter 2007/8 NICE Clinical Guideline 54: Urinary Tract Infection in Children

More information

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

Volume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.

Volume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000. Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines

More information

Antibiotic Updates: Part I

Antibiotic Updates: Part I Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

ANTIMICROBIAL STEWARDSHIP FOR AMBULATORY CARE SETTINGS

ANTIMICROBIAL STEWARDSHIP FOR AMBULATORY CARE SETTINGS ANTIMICROBIAL STEWARDSHIP FOR AMBULATORY CARE SETTINGS Jeffrey S Gerber, MD, PhD Children s Hospital of Philadelphia University of Pennsylvania School of Medicine DISCLOSURE STATEMENT I have no conflicts

More information

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX.

Antibiotic Stewardship in the Long Term Care Setting. Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc LTSRX. Antibiotic Stewardship in the Long Term Care Setting Lisa Venditti, R.Ph., FASCP, Founder and CEO Long Term Solutions Inc. 845.208.3328 LTSRX.com 1 Resistant Bacteria Crisis The Centers for Medicare &

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Antibiotic stewardship in long term care

Antibiotic stewardship in long term care Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts

More information

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca

More information

The Big Picture: Using Antibiotic Use and Surveillance Data to Better Inform Stewardship in Healthcare Settings

The Big Picture: Using Antibiotic Use and Surveillance Data to Better Inform Stewardship in Healthcare Settings The Big Picture: Using Antibiotic Use and Surveillance Data to Better Inform Stewardship in Healthcare Settings Becky Roberts, MS Get Smart: Know When Antibiotics Work Office of Antibiotic Stewardship

More information

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial

More information

Prepared: August Review: July Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide.

Prepared: August Review: July Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide. Prepared: August 2013 Review: July 2014 Common Infections. A Medicines Optimisation Antibiotic Prescribing Guide. Contents Page: Page No Why do we want to review antibiotics? 2 What do NICE say? 3 Acute

More information

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know 2011 MFMER slide-1 Skin and Soft Tissue Infections Emerging Therapies and 5 things to know Aaron Tande, MD Assistant Professor of Medicine October 27, 2017 Division of INFECTIOUS DISEASES 2011 MFMER slide-2

More information

Volume 2; Number 16 October 2008

Volume 2; Number 16 October 2008 Volume 2; Number 16 October 2008 What s new this month NHS Lincolnshire have launched a public information campaign designed to raise public awareness of the risks associated with the inappropriate use

More information

$100 $200 $300 $400 $500

$100 $200 $300 $400 $500 Skin is In Runny Noses Got to go! Hear no evil It s in the Lungs $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500 $500 $500 $500 Double Jeopardy

More information

Urinary Tract Infection Workshop

Urinary Tract Infection Workshop Urinary Tract Infection Workshop Diagnosis, sampling, antibiotic selection, recurrence, prophylaxis Nick Francis, Robin Howe, Harry Ahmed Outline Diagnosis and sampling Nick 10 min Choice of antibiotic

More information

Choosing the Best Antibiotic in Problem Outpatient Infectious Disease Cases

Choosing the Best Antibiotic in Problem Outpatient Infectious Disease Cases Choosing the Best Antibiotic in Problem Outpatient Infectious Disease Cases Dr. Earl Rubin Associate Professor Department of Pediatrics Division of Infectious Diseases Montreal Children s Hospital Disclosures

More information

Responsible use of antibiotics

Responsible use of antibiotics Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective

More information

10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections

10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics Ann Thomas, MD, MPH Oregon Public Health Division Prescribing for Respiratory Tract Infections Antibiotic use is primary

More information

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23

More information

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days Executive Summary National consensus guidelines created jointly by the Infectious Diseases Society of

More information

Update on the Diagnosis and Management of O33s Media. Leslie Herrmann MD, FAAP Pediatrician

Update on the Diagnosis and Management of O33s Media. Leslie Herrmann MD, FAAP Pediatrician Update on the Diagnosis and Management of O33s Media Leslie Herrmann MD, FAAP Pediatrician Disclosures I have no financial disclosures. Objec3ves Understand the new diagnos3c criteria for OM Know when

More information

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,

More information

Antibiotics 101: Outpatient URIs

Antibiotics 101: Outpatient URIs Antibiotics 101: Outpatient URIs B. Joseph Guglielmo, Pharm.D. Professor and Dean School of Pharmacy University of California San Francisco Disclosures No disclosures regarding conflict of interest Acute

More information

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of

More information

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015

More information

Antibiotic Stewardship in Urgent Care Current Treatment Recommendations

Antibiotic Stewardship in Urgent Care Current Treatment Recommendations Antibiotic Stewardship in Urgent Care Current Treatment Recommendations November 14, 2018 12:00 PM 1:00 PM Please call in for audio: 888-895-6448 Passcode: 519-6001 Find the slide on the event webpage:

More information

DRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May

DRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May Paediatric Antibiotic Prescribing Guideline www.oxfdahsn.g/children Magdalen Centre Nth, 1 Robert Robinson Avenue, Oxfd Science Park, OX4 4GA, United Kingdom t: +44(0) 1865 784944 e: info@oxfdahsn.g Follow

More information

Evaluating the Role of MRSA Nasal Swabs

Evaluating the Role of MRSA Nasal Swabs Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization

More information

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats Antibiotics --When Less is More Ralph Gonzales, MD, MSPH Associate Dean, Clinical Innovation School of Medicine VP, Clinical Innovation, UCSF Health Most Urgent Threats Serious Threats Multidrug-Resistant

More information

Advanced Practice Education Associates. Antibiotics

Advanced Practice Education Associates. Antibiotics Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright

More information

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Antibiotic Stewardship Program (ASP) CHRISTUS SETX Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:

More information

Antibiotic therapy of acute gastroenteritis

Antibiotic therapy of acute gastroenteritis Antibiotic therapy of acute gastroenteritis Potential goals Clinical improvement (vs control) Fecal eradication of the pathogen and decrease infectivity Prevent complications Acute gastroenteritis viruses

More information

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota

Bacterial Resistance of Respiratory Pathogens. John C. Rotschafer, Pharm.D. University of Minnesota Bacterial Resistance of Respiratory Pathogens John C. Rotschafer, Pharm.D. University of Minnesota Antibiotic Misuse ~150 million courses of antibiotic prescribed by office based prescribers Estimated

More information

Who is the Antimicrobial Steward?

Who is the Antimicrobial Steward? Who is the Antimicrobial Steward? J. Njeri Wainaina, MD FACP Assistant Professor of Medicine Division of Infectious Diseases and Section of Perioperative Medicine Disclosures None 1 Objectives Highlight

More information

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium S aureus infections: outpatient treatment Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium Intern Med J. 2005 Feb;36(2):142-3 Intern Med J. 2005 Feb;36(2):142-3 Treatment of

More information

Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017

Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017 Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017 Newsflash: Fluoroquinolones Newsflash: Fluoroquinolones Don t

More information

How to Effectively Utilize Antimicrobial Stewardship to Optimize Clinical Outcomes

How to Effectively Utilize Antimicrobial Stewardship to Optimize Clinical Outcomes How to Effectively Utilize Antimicrobial Stewardship to Optimize Clinical Outcomes Shaina Doyen, PharmD Baptist Health Louisville Clinical Pharmacy Specialist, Infectious Diseases Disclosure I have no

More information

** the doctor start the lecture with revising some information from the last one:

** the doctor start the lecture with revising some information from the last one: Page 1 of 7 ** the doctor start the lecture with revising some information from the last one: #penicillin G has a good susceptibility against gram(+ve), Neisseria (-ve) #mostly active against strep. (don

More information

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Dr Eleri Davies Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust Antimicrobial stewardship What is it? Why is it important? Treatment and management of catheter-associated

More information

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement

6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement Conflicts of Interest Disclosure Statement Getting a grasp on Antibiotic Use and Resistance: Principles of Antimicrobial Stewardship Speaker has nothing to disclose. Jacob M Kesner, PharmD UNMH PGY-2 Infectious

More information

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,

More information

Antibiotics and Duration

Antibiotics and Duration Antibiotics and Duration James A. McKinnell, M. D. David Geffen School of Medicine UCLA Los Angeles County Department of Public Health Acute Communicable Disease Control Unit 2 Appreciation Brad Spellberg

More information

Discussion Points. Decisions in Selecting Antibiotics

Discussion Points. Decisions in Selecting Antibiotics Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018 Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg

More information

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT

INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: APRIL

More information

Presenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health

Presenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health Presenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health System, Cortez, Colorado None How do AU vendors and NHSN

More information

This survey was sent only to EIN members with a pediatric infectious diseases practice.

This survey was sent only to EIN members with a pediatric infectious diseases practice. Infectious Diseases Society of America Emerging Infections Network Report for Query: Pediatric Outpatient Parenteral Antibiotic Therapy (OPAT) Overall response rate: 188/281 (66.9%) physicians responded

More information

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs?

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs? Antibiotics & treatment of Acute Bcterial Sinusitis Walid Reda Product Manager Do your antimicrobial options meet your needs? Antimicrobial Effects: What s involved? Effect in Humans: Serum concentration

More information

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption

More information

Core Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice

Core Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice National Center for Emerging and Zoonotic Infectious Diseases Core Elements of Outpatient Antibiotic Stewardship Implementing Antibiotic Stewardship Into Your Outpatient Practice Katherine Fleming-Dutra,

More information

Clinical Practice Standard

Clinical Practice Standard Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:

More information

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco Antibacterial Resistance: Research Efforts Henry F. Chambers, MD Professor of Medicine University of California San Francisco Resistance Resistance Dose-Response Curve Antibiotic Exposure Anti-Resistance

More information

The Rise of Antibiotic Resistance: Is It Too Late?

The Rise of Antibiotic Resistance: Is It Too Late? The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the

More information

Great moments in acute otitis media

Great moments in acute otitis media Great moments in acute otitis media Michael Radetsky MD CM Albuquerque NM An evidenced based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study Cates

More information